Mission statement · Company scope
“Our mission is to build a breakthrough oncology company creating neoantigen-based therapies that significantly improve the lives of patients.”
In use2018 – now1 sighting
First seenJun 2018Added
Last seenJun 2018Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Impact (primary) · Product offering · Innovation
- Leads with
- Change
- Best for
- Mission-driven · Climate & health
- Formula
- A world where [change]
- Tone
- Aspirational
- Length
- 19 words · reading grade 15.8
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_175473f5287fe062
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2018-06-28 · sec_sentence · 424B4 · accession 0001047469-18-004784
View filing ↗0 to compareCompare